Orthonika Company Profile: Valuation & Investors

Orthonika Overview

Founded
2014

Status
Private

Employees
7

Latest Deal Type
Angel

Latest Deal Amount
$1.24M

Investors
1

Orthonika General Information

Description

Developer of total meniscus replacement device designed to restore the knee biomechanics of patients. The company uses a unique material structure that replicates the structure-function relationship of the natural tissue, a novel fiber-reinforced structure embedded in a proprietary polymer, and offers service osteoarthritis treatment, knee arthroplasty, anatomical meniscus replacement services, and other knee-related treatments, enabling patients with severe meniscus injury to return to an active lifestyle and fulfill a gap of high unmet clinical needs.

Contact Information

Website

www.orthonika.com

Ownership Status

Privately Held (backing)

Financing Status

Angel-Backed

Primary Industry

Therapeutic Devices

Other Industries

Clinics/Outpatient Services

Other Devices and Supplies

Primary Office

Biomechanics Lab, Department of Mechanical Engineering
Imperial College London, South Kensington Campus
London SW7 2AZ
England, United Kingdom





Orthonika Timeline

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Orthonika Valuation & Funding

Deal Type	Date	Amount	Raised to Date	Post-Val	Status	Stage
8. Angel (individual)	28-Jun-2022	$1.24M	00.000	000.00	Completed	Generating Revenue
7. Angel (individual)	06-Nov-2019	00.000	00.000	00.000	Completed	Generating Revenue
6. Grant	01-Oct-2019	00000	00.00		Completed	Generating Revenue
5. Grant	01-Jul-2017	00000	00.00		Completed	Generating Revenue
4. Angel (individual)	15-May-2017	00000	00.00		Completed	Generating Revenue
3. Grant	01-Feb-2017	00000	00000		Completed	Generating Revenue
2. Seed Round	03-Aug-2015	$234K	$234K	00000	Completed	Generating Revenue
1. Spin-Off	18-Dec-2014				Completed	Startup

To view Orthonika’s complete valuation and funding history, request access »

Orthonika Cap Table

Stock	# of Shares Authorized	Par Value	Original Issue Price	Liquidation	Conversion Price	% Owned
Ordinary	00,000	00.000000	000.00	000.00	000.00	00.000
Ordinary	00,000	00.000000	000.00	000.00	000.00	0.000
Ordinary	15,699	$0.001236	$29.53	$29.53	$29.53	6.77%
Ordinary	25,000	$0.001236	$6.18	$6.18	$6.18	10.78%

To view Orthonika’s complete cap table history, request access »

Orthonika Patents

9
Total Documents Applications and Grants
000
Total Patents Families
2
Granted
000
Pending
000
Expiring in next 12 mo

Orthonika Recent Patent Activity

Publication ID	Patent Title	Status	First Filing Date	Technology (CPC)	Citations
EP-3618774-A4	Composite joint implant	Pending	02-May-2017	0000000000	0
US-11452606-B2	Composite joint implant	Active	02-May-2017	0000000000	000
US-20200060834-A1	Composite joint implant	Active	02-May-2017	0000000000
US-20230086215-A1	Composite joint implant	Pending	02-May-2017	0000000000
EP-3200728-A1	Anatomically designed meniscus implantable devices	Active	02-Oct-2014	A61F2/3872

To view Orthonika’s complete patent history, request access »

Orthonika Executive Team (4)

Name	Title	Board Seat	Contact Info
Mario Accardi Ph.D	Co-Founder, Chief Executive Officer & Executive Chairman
Dominique Kleyn	Co-Founder, Chief Operating Officer & Board Member
Maria Bartolo Ph.D	Chief Technology Officer
Andrew Amis	Co-Founder, Technical Director & Board Member

To view Orthonika’s complete executive team members history, request access »

Orthonika Board Members (5)

Name	Representing	Role
Andrew Amis	Orthonika	Co-Founder, Technical Director & Board Member
Dominique Kleyn	Orthonika	Co-Founder, Chief Operating Officer & Board Member
Justin Cobb	Self	Co-Founder, Clinical Advisor & Board Member
Mario Accardi Ph.D	Orthonika	Co-Founder, Chief Executive Officer & Executive Chairman
Max Graziosi	Orthonika	Board Member